CD4 and systemic sclerosis: By validating the diagnostic accuracy of this threshold (Figure 3B), we observed SSc patients had a substantial increase in CVD risk when the Th (CD3+CD4+) cell count exceeded 866.53 cells/μL (p <0.001).